BARRIERS TO LATINO PARTICIPATION IN CLINICAL TRIALS

拟议的两年特别项目将继续由 东部肿瘤学合作肿瘤学小组将增加少数民族 参与和登记癌症临床试验。这个 这一应计项目将在印第安纳州继续进行。 大学，这是经社理事会的成员机构。具体地说，这个项目将 调查拉美裔美国人罹患癌症的障碍 注重社区初级保健作用的预防试验 医生。该项目的一项主要活动将涉及以下重点小组 拉丁裔医生和ECOG医生位于 数量可观的拉丁裔人口。焦点的主要目标 小组/讲习班是：(1)确定参与的障碍并对其进行排序 参与癌症预防试验的拉丁裔患者；(2)开发和测试网站- 针对以下方面确定的障碍的特定和基于社区的解决方案 医生焦点小组；(3)评估和测量焦点小组的影响 通过拉丁裔参与由医生焦点选择的临床试验 以及(4)将成功的解决方案输出到其他 拉美裔美国人。

The proposed two year special project will continue a program initiated by the Eastern Oncology Cooperative Oncology Group to increase minority participation and enrollment into cancer clinical trials. The continuation of this accrual project will be conducted at Indiana University, an ECOG member institution. Specifically, this project will investigate barriers to the enrollment of Latino Americans into cancer prevention trials focusing upon the role of the community primary care physician. A major activity of the project will involve focus groups with Latino physicians and ECOG physicians who are located in areas with significant Latino populations. Major objectives of the focus group/workshops are: (1) To identify and rank barriers to participation of Latino patients in cancer prevention trials; (2) To develop and test site- specific and community based solutions to barriers identified from physician focus groups; (3) To evaluate and measure impact of focus groups by participation of Latinos in clinical trials selected by physician focus groups; and (4) To export successful solutions to common barriers to other Hispanic Americans.